BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29283494)

  • 1. Genetic association of complement component 2 variants with chronic hepatitis B in a Korean population.
    Namgoong S; Shin JG; Cheong HS; Kim LH; Kim JO; Seo JY; Shin HD; Kim YJ
    Liver Int; 2018 Sep; 38(9):1576-1582. PubMed ID: 29283494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-synonymous variant rs12614 of complement factor B associated with risk of chronic hepatitis B in a Korean population.
    Seo JY; Shin JG; Youn BJ; Namgoong S; Cheong HS; Kim LH; Kim JO; Shin HD; Kim YJ
    BMC Med Genet; 2020 Dec; 21(1):241. PubMed ID: 33334325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome-wide association study for persistent hepatitis B virus infection and related hepatocellular carcinoma.
    Han J; Chen C; Wang C; Qin N; Huang M; Ma Z; Zhu M; Dai J; Jiang Y; Ma H; Jin G; Shen H; Hu Z
    Liver Int; 2020 Sep; 40(9):2117-2127. PubMed ID: 32574393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of interferon gamma gene and risk of hepatocellular carcinoma in Korean patients with chronic hepatitis B viral infection.
    Kim HJ; Chung JH; Shin HP; Jeon JW; Park JJ; Cha JM; Joo KR; Lee JI
    Hepatogastroenterology; 2013; 60(128):2080-4. PubMed ID: 24719951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel OCT4 genetic variant associated with the risk of chronic hepatitis B in a Korean population.
    Shin JG; Cheong HS; Lee K; Ju BG; Lee JH; Yu SJ; Yoon JH; Cheong JY; Cho SW; Park NH; Namgoong S; Kim LH; Kim YJ; Shin HD
    Liver Int; 2017 Mar; 37(3):354-361. PubMed ID: 27596359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms in complement receptor 1 gene and its association with HBV-related liver disease: A case-control study.
    Luo J; Chen S; Wang J; Ou S; Zhang W; Liu Y; Qin Z; Xu J; Lu Q; Mo C; Li S; Qin X
    Gene; 2019 Mar; 688():107-118. PubMed ID: 30529247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants of interferon regulatory factor 5 associated with chronic hepatitis B infection.
    Sy BT; Hoan NX; Tong HV; Meyer CG; Toan NL; Song LH; Bock CT; Velavan TP
    World J Gastroenterol; 2018 Jan; 24(2):248-256. PubMed ID: 29375210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of VARS2-SFTA2 polymorphisms with the risk of chronic hepatitis B in a Korean population.
    Cheong HS; Lee JH; Yu SJ; Yoon JH; Lee HS; Cheong JY; Cho SW; Park NH; Park BL; Namgoong S; Kim LH; Shin HD; Kim YJ
    Liver Int; 2015 Aug; 35(8):1934-40. PubMed ID: 25404243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of interferon gamma gene and risk of hepatocellular carcinoma in korean patients with chronic hepatitis B viral infection.
    Kim HJ; Chung JH; Shin HP; Jeon JW; Park JJ; Cha JM; Joo KR; Lee JI
    Hepatogastroenterology; 2013; 60(125):1117-20. PubMed ID: 23803376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between HLA-G 14-bp insertion/deletion polymorphism and hepatocellular carcinoma in Korean patients with chronic hepatitis B viral infection.
    Kim SK; Chung JH; Jeon JW; Park JJ; Cha JM; Joo KR; Lee JI; Shin HP
    Hepatogastroenterology; 2013 Jun; 60(124):796-8. PubMed ID: 23732778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPP1 polymorphisms associated with HBV clearance and HCC occurrence.
    Shin HD; Park BL; Cheong HS; Yoon JH; Kim YJ; Lee HS
    Int J Epidemiol; 2007 Oct; 36(5):1001-8. PubMed ID: 17496055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.
    Sawai H; Nishida N; Khor SS; Honda M; Sugiyama M; Baba N; Yamada K; Sawada N; Tsugane S; Koike K; Kondo Y; Yatsuhashi H; Nagaoka S; Taketomi A; Fukai M; Kurosaki M; Izumi N; Kang JH; Murata K; Hino K; Nishina S; Matsumoto A; Tanaka E; Sakamoto N; Ogawa K; Yamamoto K; Tamori A; Yokosuka O; Kanda T; Sakaida I; Itoh Y; Eguchi Y; Oeda S; Mochida S; Yuen MF; Seto WK; Poovorawan Y; Posuwan N; Mizokami M; Tokunaga K
    Sci Rep; 2018 May; 8(1):7958. PubMed ID: 29784950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of interleukin-12 gene polymorphism with persistence of hepatitis B virus infection and hepatocellular carcinoma].
    Park JS; Cheong JY; Kang JK; Cho JH; Yu S; Shin HD; Park BL; Cho SW
    Korean J Gastroenterol; 2007 Nov; 50(5):313-8. PubMed ID: 18159163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Yoon YJ; Chang HY; Ahn SH; Kim JK; Park YK; Kang DR; Park JY; Myoung SM; Kim DY; Chon CY; Han KH
    Carcinogenesis; 2008 Jun; 29(6):1192-6. PubMed ID: 18390844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
    Hu L; Zhai X; Liu J; Chu M; Pan S; Jiang J; Zhang Y; Wang H; Chen J; Shen H; Hu Z
    Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.
    Cheong JY; Shin HD; Cho SW; Kim YJ
    J Korean Med Sci; 2014 Nov; 29(11):1523-7. PubMed ID: 25408584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A trivial role of STAT4 variant in chronic hepatitis B induced hepatocellular carcinoma.
    Clark A; Gerlach F; Tong Hv; Hoan NX; Song le H; Toan NL; Bock CT; Kremsner PG; Velavan TP
    Infect Genet Evol; 2013 Aug; 18():257-61. PubMed ID: 23748017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers.
    Yu MW; Chiu YH; Yang SY; Santella RM; Chern HD; Liaw YF; Chen CJ
    Br J Cancer; 1999 May; 80(3-4):598-603. PubMed ID: 10408872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrence.
    Kim JH; Yu SJ; Park BL; Cheong HS; Pasaje CF; Bae JS; Lee HS; Shin HD; Kim YJ
    Dig Dis; 2011; 29(3):278-83. PubMed ID: 21829018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.